)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Axonics
Axonics (AXNX) investor relations material
Axonics has been acquired by Boston Scientific Corporation
Axonics Q3 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2024 earnings summary7 Nov, 2024
Executive summary
Q3 2024 net revenue was $116.2M, up 25% year-over-year, driven by increased U.S. product sales and new account onboarding for sacral neuromodulation and Bulkamid.
Gross margin improved to 77.2% from 74.2% in Q3 2023, reflecting higher sales volumes and favorable product mix.
Operating expenses rose due to higher legal, personnel, marketing, R&D, and one-time litigation and merger-related fees.
Net loss for Q3 2024 was $21,000, compared to net income of $3.9M in Q3 2023, impacted by $8M in one-time legal and acquisition-related costs.
The pending merger with Boston Scientific remains under FTC review, with all closing conditions not yet satisfied.
Financial highlights
Q3 2024 net revenue: $116.2M (+25% YoY); nine months: $322.2M (+25.5% YoY).
Sacral neuromodulation revenue (Q3): $92.3M; Bulkamid revenue (Q3): $23.8M, both up 25% year-over-year.
Gross profit for Q3: $89.7M; gross margin: 77.2% (vs. 74.2% prior year).
Adjusted EBITDA: $23.6M vs. $14.0M prior year.
Cash, cash equivalents, short-term investments, and restricted cash totaled $367M as of September 30, 2024.
Outlook and guidance
Cash on hand expected to fund operations for at least the next 12 months.
Revenue expected to fluctuate quarterly due to seasonality and market factors.
Ongoing investments in sales, marketing, and R&D to support growth and product innovation.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Axonics
Axonics
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Axonics, Inc. is a medical technology company specializing in implantable devices for the treatment of bladder and bowel dysfunction. The company develops and markets sacral neuromodulation systems designed to provide long-term relief for patients with conditions such as overactive bladder, urinary retention, and fecal incontinence. Axonics focuses on innovative, patient-friendly solutions that enhance the quality of life and offer alternatives to traditional treatments. The company is headquartered in Irvine, California, and its shares are listed on the NASDAQ.